The rising prevalence of urticaria is fueling market growth, with increased allergic responses and lifestyle shifts playing key roles. Advances in biologic treatments and a strong development pipeline ...

AbbVie, a global, research-driven biopharmaceutical company, organized a visit to its R&D facilities—the AbbVie Cambridge ...

BioDuro-Sundia opens new kilogram laboratory at Shanghai to speed development from discovery to preclincal and clinical ...

As the pharmaceutical industry rapidly transforms, companies seeking to achieve and hold the leading positions on the market ...

Innovative products, such as those being developed by DELFI, will aid in the efficient progress of those medicines through the clinic," said Susan Macdonald, PhD, SVP Nonclinical Development & ...

Kochi: Amrita Hospital has commenced the third phase of testing for the 'Dengue All' vaccine, marking a significant milestone ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy ...

Mortenson and The University of Minnesota Foundation Real Estate Advisors (UMFREA) have announced that CBRE has been selected ...

biomodal, an omics-based life sciences technology and analytics company, today announced it will present new data highlighting the utility of duet mul ...